Coherus BioSciences Inc (CHRS)

NASDAQ HEALTHCARE
$1.54 -5.52% RSI 51 Neutral Add Alert

Moving Averages

SMA 200
$1.62
Price below

Company Profile

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$237.55M
P/E Ratio
None
EPS
$-1.42
Beta
0.979
Dividend Yield
0.00%
52-Week High
$2.616
52-Week Low
$0.81

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 51.0
CRSP
CRISPR Therapeutics AG
RSI 41.0
MRNA
Moderna Inc
RSI 55.0
VKTX
Viking Therapeutics Inc
RSI 59.0
SRPT
Sarepta Therapeutics Inc
RSI 56.0
EDIT
Editas Medicine Inc
RSI 55.0
IOVA
Iovance Biotherapeutics Inc
RSI 53.0
NVAX
Novavax Inc
RSI 51.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 49.0

Data last updated: July 13, 2026 at 2:04 AM EDT

Track CHRS for free

Get e-mail RSI alerts when Coherus BioSciences Inc enters oversold or overbought territory. Free forever.

Add Alert